MedTrace Logo

HER Salt Lake Initiative

NCT02734199 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4430

Last updated 2021-04-28

No results posted yet for this study

Summary

This study aims to understand the long-term health, social, and economic impacts of transitioning a community to Highly Effective Reversible Contraception (HER-C).

Conditions

  • Birth Control
  • Contraception

Sponsors & Collaborators

Principal Investigators

  • David K Turok, MD · University of Utah, Department of Obstetrics & Gynecology

Eligibility

Min Age
16 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2020-03-31
Completion
2020-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02734199 on ClinicalTrials.gov